Skip to main content
Erschienen in: Pediatric Cardiology 2/2006

01.04.2006

Management Strategy for Very Mild Aortic Valve Stenosis

verfasst von: P.J. Bartz, D.J. Driscoll, J.F. Keane, W.M. Gersony, C.J. Hayes, J.I. Brenner, W.M. O’Fallon, D.R. Pieroni, R.R. Wolfe, W.H. Weidman

Erschienen in: Pediatric Cardiology | Ausgabe 2/2006

Einloggen, um Zugang zu erhalten

Abstract

It is unclear how often patients with very mild aortic stenosis (gradients <25 mmHg) need interval follow-up. The purpose of this study was to define the determinants of disease severity progression and to propose appropriate management strategies. It is known that congenital aortic stenosis is a progressive disease that requires long-term follow-up at consistent intervals. We studied 89 patients with very mild aortic stenosis. Cox proportional hazard modeling was performed to ascertain predictors of morbidity and mortality. Events were defined as valve surgery or death. Of the original 89 patients, 7 died (92% survival); one death was sudden and unexplained and six were noncardiac. Eighteen individuals were lost to follow-up (10 not located and 8 refused participation). Twelve (17%) had valve surgery. The minimum time interval between initial diagnosis of very mild aortic stenosis and surgery was 4.6 years (mean, 14.0). Age at diagnosis, gender, initial gradient, initial gradient/age, and aortic regurgitation were found not to be predictive of outcome. However, the slope of the transaortic gradient [change of gradient/time (years)] was predictive of outcome (hazard ratio of 1.69; confidence interval, 1.4–2.2). At least 17% of these patients progress to require operation. For patients with a gradient slope <1.1, evaluation every 4 or 5 years is recommended. For patients with a gradient slope >1.2, evaluation every 1 or 2 years seems prudent.
Literatur
1.
Zurück zum Zitat Bengur AR, Snider AR, Serwer GA, Peters J, Rosenthal A (1989) Usefulness of the Doppler mean gradient in evaluation of children with aortic valve stenosis and comparison to gradient at catheterization. Am J Cardiol 64:756–761CrossRefPubMed Bengur AR, Snider AR, Serwer GA, Peters J, Rosenthal A (1989) Usefulness of the Doppler mean gradient in evaluation of children with aortic valve stenosis and comparison to gradient at catheterization. Am J Cardiol 64:756–761CrossRefPubMed
2.
Zurück zum Zitat Ferencz C, Rubin JD, McCarter RJ, et al. (1985) Congenital heart disease; prevalence at livebirth. The Baltimore–Washington Infant Study. Am J Epidemiol 121:31–36PubMed Ferencz C, Rubin JD, McCarter RJ, et al. (1985) Congenital heart disease; prevalence at livebirth. The Baltimore–Washington Infant Study. Am J Epidemiol 121:31–36PubMed
3.
Zurück zum Zitat Keane JF, Driscoll DJ, Gersony WM, et al. (1993) Second natural history study of congenital heart defects. Results of treatment of patients with aortic valvar stenosis. Circulation 56:I5–I12PubMed Keane JF, Driscoll DJ, Gersony WM, et al. (1993) Second natural history study of congenital heart defects. Results of treatment of patients with aortic valvar stenosis. Circulation 56:I5–I12PubMed
4.
Zurück zum Zitat Kitchiner D, Jackson M, Malaiya N, et al. (1994) Incidence and prognosis of obstruction of the left vpntricular outflow tract in Liverpool (1960–91): a study of 313 patients. Br Heart J 71:588–595PubMed Kitchiner D, Jackson M, Malaiya N, et al. (1994) Incidence and prognosis of obstruction of the left vpntricular outflow tract in Liverpool (1960–91): a study of 313 patients. Br Heart J 71:588–595PubMed
5.
Zurück zum Zitat Miettinen OS, Rees JK (1977) Report from the Joint Study on the Natural History of Congenital Heart Defects. II. Methodology. Circulation 56:I5–I12PubMed Miettinen OS, Rees JK (1977) Report from the Joint Study on the Natural History of Congenital Heart Defects. II. Methodology. Circulation 56:I5–I12PubMed
6.
Zurück zum Zitat O’Fallon WM, Crowson CS, Rings LJ, et al. (1993) Second natural history study of congenital heart defects. Materials and methods. Circulation 87:I4–I15PubMed O’Fallon WM, Crowson CS, Rings LJ, et al. (1993) Second natural history study of congenital heart defects. Materials and methods. Circulation 87:I4–I15PubMed
7.
Zurück zum Zitat Rubin JD, Ferencz C, McCarter RJ, et al. (1985) Congenital cardiovascular malformations in the Baltimore–Washington area. Md Med J 34:1079–1083PubMed Rubin JD, Ferencz C, McCarter RJ, et al. (1985) Congenital cardiovascular malformations in the Baltimore–Washington area. Md Med J 34:1079–1083PubMed
8.
Zurück zum Zitat Wagner HR, Ellison RC, Keane JF, Humphries OJ, Nadas AS (1977) Clinical course in aortic stenosis. Circulation 56:I47–I56PubMed Wagner HR, Ellison RC, Keane JF, Humphries OJ, Nadas AS (1977) Clinical course in aortic stenosis. Circulation 56:I47–I56PubMed
Metadaten
Titel
Management Strategy for Very Mild Aortic Valve Stenosis
verfasst von
P.J. Bartz
D.J. Driscoll
J.F. Keane
W.M. Gersony
C.J. Hayes
J.I. Brenner
W.M. O’Fallon
D.R. Pieroni
R.R. Wolfe
W.H. Weidman
Publikationsdatum
01.04.2006
Erschienen in
Pediatric Cardiology / Ausgabe 2/2006
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-005-1134-x

Weitere Artikel der Ausgabe 2/2006

Pediatric Cardiology 2/2006 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.